SCHEMBL3963266

SCHEMBL3963266

CC(C)C(C)CN(C(=O)/C=C/c1ccccc1)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TRPM8 Q7Z2W7 7/20 0.48
ALDH1A1 P00352 5/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 2/20 0.45
GLA P06280 1/20 0.45
MDM2 Q00987 1/20 0.43
HDAC3 O15379 1/20 0.43
TNKS O95271 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10316760 0.79 NPC1 (0.64) NPC1L3MBTL1TRPM8ALDH1A1TDP1
SCHEMBL10317122 0.79 NPC1 (0.64) NPC1L3MBTL1TRPM8ALDH1A1TDP1
SCHEMBL11965212 0.74 NPC1 (0.57) NPC1L3MBTL1TRPM8ALDH1A1TDP1
SCHEMBL11965213 0.74 NPC1 (0.57) NPC1L3MBTL1TRPM8ALDH1A1TDP1
SCHEMBL10698513 0.73 NPC1 (0.56) NPC1L3MBTL1TRPM8ALDH1A1TDP1
SCHEMBL9735646 0.71 NPC1 (0.53) NPC1L3MBTL1TRPM8ALDH1A1TDP1
N,N-Dimethylcinnamamide SCHEMBL783551 0.70 NPC1 (0.65) NPC1L3MBTL1TRPM8ALDH1A1TDP1
N,N-Dimethylcinnamamide SCHEMBL3743395 0.70 NPC1 (0.65) NPC1L3MBTL1TRPM8ALDH1A1TDP1
SCHEMBL3963263 0.70 TRPM8 (0.54) NPC1L3MBTL1TRPM8ALDH1A1TDP1
N,N-Diethylcinnamamide SCHEMBL23550023 0.69 NPC1 (1.00) NPC1L3MBTL1TRPM8ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7560473-B2 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES, P.L.A. (CN) 2009-07-14 US claimed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN claimed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 US claimed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 EP claimed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN claimed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN claimed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN claimed
US-7560473-B2 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES, P.L.A. (CN) 2009-07-14 US disclosed
CN-1250519-C Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
CN-1250518-C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN disclosed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 US disclosed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 EP disclosed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN disclosed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN disclosed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use KCNMA1, KCNA5, KCNA1 NPC1 3722/4885L3MBTL1 2902/4885TRPM8 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.